Skip to main content

Advertisement

SpringerLink
Log in

Medication changes and potentially inappropriate prescribing in older patients with significant polypharmacy

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background

Number of medicines and medicines appropriateness are often used as outcome measures to evaluate the effectiveness of deprescribing interventions.

Aim

The aim of this study was to evaluate changes in prescribing, potentially inappropriate prescriptions (PIP) and prescribing of low-value medicines in older people with multimorbidity and significant polypharmacy.

Method

This study was a retrospective secondary analysis of prescription data from a cluster randomised controlled trial involving 404 participants aged ≥ 65 years and prescribed ≥ 15 repeat medicines from 51 different general practices. For this study, repeat medications at baseline and follow-up (~ 1 year later) were assigned Anatomical Therapeutic Classification (ATC) codes. Outcomes were the most commonly prescribed and potentially inappropriately prescribed drug groups, the most frequently discontinued or initiated drug groups and the number of changes per person between baseline and follow-up.

Results

There were 7051 medicines prescribed to 404 participants at baseline. There was a median of 17 medicines (IQR 15–19) at baseline and 16 (IQR 14–19) at follow-up. PIP represented 17.1% of prescriptions at baseline and 15.7% (n = 6777) at follow-up. There were reductions in the prescription of most drug groups with the largest reduction in antiplatelet prescriptions. Considering medication discontinuations, initiations and switches, there was a median of five medication changes per person (range 0–30, IQR 3–9) by follow-up. There were 95 low-value prescriptions at baseline reducing to 78 at follow-up.

Conclusion

The number of medication changes per person was not reflected by summarising medication count at two time points, highlighting the complexity of prescribing for patients with polypharmacy. Frequent medication changes has potentially important implications for patients in terms of adherence and medication safety.

Trial registry

The SPPiRE trial was registered prospectively on the ISRCTN registry (ISRCTN12752680).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Fortin M, Stewart M, Poitras ME, et al. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med. 2012;10(2):142–51.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Khezrian M, McNeil CJ, Murray AD, et al. An overview of prevalence, determinants and health outcomes of polypharmacy. Therapeut Adv Drug Saf. 2020;11:2042098620933741.

    Google Scholar 

  3. Masnoon N, Shakib S, Kalisch-Ellett L, et al. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: How well can it be measured and optimised? Lancet. 2007;370(9582):173–84.

    Article  PubMed  Google Scholar 

  5. Wallace J, Paauw DS. Appropriate prescribing and important drug interactions in older adults. Med Clin North Am. 2015;99(2):295–310.

    Article  PubMed  Google Scholar 

  6. Guthrie B, McCowan C, Davey P, et al. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ. 2011;342:d3514.

    Article  PubMed  Google Scholar 

  7. Payne RA, Abel GA, Avery AJ, et al. Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care. Br J Clin Pharmacol. 2014;77(6):1073–82.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Scottish Government Model of Care Polypharmacy Working Group. Polypharmacy guidance. 2nd ed. NHS Scotland: Scottish Government; 2015.

    Google Scholar 

  9. American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. Guiding principles for the care of older adults with multimorbidity: an approach for clinicians. J Am Geriatr Soc. 2012;60(10):E1-25.

    Article  PubMed Central  Google Scholar 

  10. Multimorbidity: assessment, prioritisation and management of care for people with commonly occurring multimorbidity. NICE Guideline. NICE; 2016. [Available from: https://www.nice.org.uk/guidance/ng56 Accessed 27 Sep 2022

  11. Moriarty F, Hardy C, Bennett K, et al. Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study. BMJ Open. 2015;5(9):e008656.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Avery AJ, Bell BG. Rationalising medications through deprescribing. BMJ. 2019;364:l570.

    Article  PubMed  Google Scholar 

  13. Gnjidic D, Le Couteur DG, Kouladjian L, et al. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med. 2012;28(2):237–53.

    Article  PubMed  Google Scholar 

  14. McCarthy C, Clyne B, Corrigan D, et al. Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot. Implement Sci. 2017;12(1):99.

    Article  PubMed  PubMed Central  Google Scholar 

  15. McCarthy C, Clyne B, Boland F, et al. GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): a cluster randomised controlled trial. PLoS Med. 2022;19(1):e1003862.

    Article  PubMed  PubMed Central  Google Scholar 

  16. McCarthy C, Moriarty F, Wallace E, et al. The evolution of an evidence based intervention designed to improve prescribing and reduce polypharmacy in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE). J Comorbid. 2020;10:2235042X2094624. https://doi.org/10.1177/2235042X20946243.

    Article  Google Scholar 

  17. Items which should not routinely be prescribed in primary care: Guidance for CCGs Version 2: NHS England and NHS Improvement; 2019 [Available from: https://www.england.nhs.uk/wp-content/uploads/2019/08/items-which-should-not-routinely-be-prescribed-in-primary-care-v2.1.pdf. Accessed 27 Sep 2022

  18. Stephenson A, Seitz D, Bell CM, et al. Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study. Arch Intern Med. 2011;171(10):914–20.

    Article  CAS  PubMed  Google Scholar 

  19. Dreischulte T, Grant AM, McCowan C, et al. Quality and safety of medication use in primary care: consensus validation of a new set of explicit medication assessment criteria and prioritisation of topics for improvement. BMC Clin Pharmacol. 2012;12:5.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ. 2004;329(7456):15–9.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007;63(2):136–47.

    Article  CAS  PubMed  Google Scholar 

  22. Lam KD, Miao Y, Steinman MA. Cumulative changes in the use of long-term medications: a measure of prescribing complexity. JAMA Int Med. 2013;173(16):1546–7.

    Article  Google Scholar 

  23. von Buedingen F, Hammer MS, Meid AD, et al. Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice. BMC Fam Pract. 2018;19(1):131.

    Article  Google Scholar 

  24. Radomski TR, Decker A, Khodyakov D, et al. Development of a metric to detect and decrease low-value prescribing in older adults. JAMA Network Open. 2022;5(2):e2148599.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Falster MO, Charrier R, Pearson SA, et al. Long-term trajectories of medicine use among older adults experiencing polypharmacy in Australia. Br J Clin Pharmacol. 2021;87(3):1264–74.

    Article  PubMed  Google Scholar 

  26. García Rodríguez LA, Cea Soriano L, de Abajo FJ, et al. Trends in the use of oral anticoagulants, antiplatelets and statins in four European countries: a population-based study. Eur J Clin Pharmacol. 2022;78(3):497–504.

    Article  PubMed  Google Scholar 

  27. Piepoli MF, Hoes AW, Agewall S, et al. European Guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–81.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Bloom CI, Elkin SL, Quint JK. Changes in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016. Int J Chron Obstruct Pulmon Dis. 2019;14:279–87.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Smith A, Barry M. Oral anticoagulants - utilisation and expenditure under the community drugs schemes. Ir Med J. 2020;113(5):71.

    CAS  PubMed  Google Scholar 

  30. NMIC bulletin: prescribing in the elderly Dublin: St James's Hospital, Dublin; 2010 [Available from: http://www.stjames.ie/GPsHealthcareProfessionals/Newsletters/NMICBulletins/NMICBulletinIndexbyYear/. Accessed 27 Sep 2022.

  31. Gray SL, Hanlon JT. Anticholinergic medication use and dementia: latest evidence and clinical implications. Ther Adv Drug Saf. 2016;7(5):217–24.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Dauphinot V, Mouchoux C, Veillard S, et al. Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders. Alzheimers Res Ther. 2017;9(1):58.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Avery AJ, Rodgers S, Cantrill JA, et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. The Lancet. 2012;379(9823):1310–9.

    Article  Google Scholar 

  34. Cardwell K, Smith SM, Clyne B, et al. Evaluation of the General Practice Pharmacist (GPP) intervention to optimise prescribing in Irish primary care: a non-randomised pilot study. BMJ Open. 2020;10(6):e035087.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Levinson W, Kallewaard M, Bhatia RS, et al. ‘Choosing Wisely’: a growing international campaign. BMJ Qual Saf. 2015;24(2):167–74.

    Article  PubMed  Google Scholar 

  36. Grimshaw JM, Patey AM, Kirkham KR, et al. De-implementing wisely: developing the evidence base to reduce low-value care. BMJ Qual Saf. 2020;29(5):409–17.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Barry M. Lidocaine 700 mg medicated plaster (Versatis®) Prescribing and Cost Guidance: Health Service Executive; 2021 [updated 21/04/2021. Available from: https://www.hse.ie/eng/services/publications/clinical-strategy-and-programmes/lidocaine-versatis-prescribing-cost-summary.pdf. Accessed 27 Sep 2022.

  38. Sumukadas D, McMurdo ME, Mangoni AA, et al. Temporal trends in anticholinergic medication prescription in older people: repeated cross-sectional analysis of population prescribing data. Age Age. 2014;43(4):515–21.

    Article  Google Scholar 

Download references

Funding

This research is funded by the HRB Primary Care Clinical Trial’s Network, Ireland (https://primarycaretrials.ie/) HRB CTN2014-011.

Author information

Authors and Affiliations

  1. HRB Centre for Primary Care Research, Department of General Practice, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland

    Caroline McCarthy, Barbara Clyne, Susan M. Smith, Emma Wallace, Fiona Boland & Frank Moriarty

  2. School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin 2, Ireland

    Michelle Flood & Frank Moriarty

  3. Department of Public Health and Primary Care, Trinity College Dublin, Dublin 2, Ireland

    Susan M. Smith

  4. Data Science Centre, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin 2, Ireland

    Fiona Boland

Authors
  1. Caroline McCarthy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michelle Flood
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Barbara Clyne
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Susan M. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Emma Wallace
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fiona Boland
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Frank Moriarty
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Caroline McCarthy.

Ethics declarations

Conflicts of interest

The authors have no conflict of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 220 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McCarthy, C., Flood, M., Clyne, B. et al. Medication changes and potentially inappropriate prescribing in older patients with significant polypharmacy. Int J Clin Pharm 45, 191–200 (2023). https://doi.org/10.1007/s11096-022-01497-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-022-01497-2

Keywords

Search

Navigation